YS, J., CW, C., CA, L., HP, Y., HY, L., MY, L., . . . PS, L. (2017). Hyaluronic acid–nimesulide conjugates as anticancer drugs against CD44-overexpressing HT-29 colorectal cancer in vitro and in vivo. Dove Medical Press.
Chicago Style (17th ed.) CitationYS, Jian, Chen CW, Lin CA, Yu HP, Lin HY, Liao MY, Wu SH, Lin YF, and Lai PS. Hyaluronic Acid–nimesulide Conjugates as Anticancer Drugs Against CD44-overexpressing HT-29 Colorectal Cancer in Vitro and in Vivo. Dove Medical Press, 2017.
MLA (8th ed.) CitationYS, Jian, et al. Hyaluronic Acid–nimesulide Conjugates as Anticancer Drugs Against CD44-overexpressing HT-29 Colorectal Cancer in Vitro and in Vivo. Dove Medical Press, 2017.
Warning: These citations may not always be 100% accurate.